Neuraly, Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH (NCT06410924) | Neuraly, Inc. | 2024-06-13 |
| A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD (NCT04812262) | Neuraly, Inc. | 2021-02-24 |
| A Study With NLY01 in Subjects With Type 2 Diabetes (NCT04159766) | Neuraly, Inc. | 2019-10-16 |
| A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects (NCT03672604) | Neuraly, Inc. | 2018-09-19 |
Track Neuraly, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.